NIH-funded research Fellowship grant

How Toxoplasma gondii affects immune cell balance

Official title: Impact of Toxoplasma gondii on Treg homeostasis

Funded at University of Pennsylvania · NIH-10901125 · Data updated 2026-11-12

This study looks at how the Toxoplasma gondii parasite affects a type of immune cell called regulatory T cells, focusing on what happens to these cells during and after an infection, to help us understand how our immune system works and find new ways to treat related health issues.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2024
Project endJuly 31, 2027
Funding year2024
Award (this year)$48,974
NIH project number1F31AI179240-01A1
Project IDNIH-10901125 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with chronic infections or immune system disorders that may be influenced by Treg dynamics.

Less likely to help

Patients without chronic infections or those whose immune system function is not affected by Toxoplasma gondii may not benefit from this research.

What this research studies

This research investigates how the parasite Toxoplasma gondii impacts the population of regulatory T cells (Tregs) in the immune system. It focuses on understanding the collapse of Treg cells during acute infection and how these cells rebuild over time. The study aims to identify the cytokines involved in Treg repopulation and whether chronic inflammation alters Treg characteristics. By examining these processes, the research seeks to provide insights into immune responses and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for conditions related to immune system dysfunction.

How similar studies have gone: Previous research has shown that understanding Treg dynamics in various infections can lead to significant advancements in immunology, suggesting this approach has potential for success.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Lanzar, Zachary R — University of Pennsylvania
  • Study coordinator: Lanzar, Zachary R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.